DESTINY-Breast04 e a revolução no tratamento do câncer de mama
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Unfollow podcast failed
DESTINY-Breast04 e a revolução no tratamento do câncer de mama
-
Narrated by:
-
By:
About this listen
Os oncologistas do Centro de Oncologia e Hematologia Einstein, Dr. Rafael Kaliks e Dra. Heloísa Veasey, juntamente com a patologista do Einstein, Dra. Eduarda Damasceno, destacam o estudo DESTINY-Breast04, fase 3, randomizado, que compara o uso do anticorpo conjugado Deruxtecan em relação ao tratamento por quimioterapia em casos de câncer de mama.
No reviews yet